Radioactive plaque therapy

International Ophthalmology Clinics

Volumn 46, Issue 1, 2006, Pages 51-68

  Hui, Jennifer I ^a   Murray, Timothy G ^b  

^a HCC   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COBALT 60; GOLD 198; IODINE 125; IRIDIUM 192; PALLADIUM 103; RADON; RUBIDIUM; RUTHENIUM 106;

BRACHYTHERAPY; CANCER CONTROL; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURVIVAL; CATARACT; CHOROID MELANOMA; CLINICAL TRIAL; CONJUNCTIVA DISEASE; DEVICE REMOVAL; DIAGNOSTIC IMAGING; DIPLOPIA; DOSIMETRY; ECHOGRAPHY; ENUCLEATION; HELIUM ION RADIATION; HISTORY; HUMAN; ILLUMINATION; INTERMETHOD COMPARISON; LIGHT EMITTING DIODE; METASTASIS; NEOVASCULAR GLAUCOMA; OPTIC NERVE DISEASE; OUTCOME ASSESSMENT; PATIENT SAFETY; PEROPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; RADIOACTIVE PLAQUE THERAPY; RETINOPATHY; REVIEW; SURGICAL TECHNIQUE; SURVIVAL RATE; THERAPY EFFECT; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME; UVEA MELANOMA; VISUAL ACUITY; VITREOUS HEMORRHAGE; CHOROID TUMOR; MELANOMA; METHODOLOGY;

BRACHYTHERAPY; CHOROID NEOPLASMS; HUMANS; MELANOMA; TREATMENT OUTCOME;

EID: 33644876278     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.iio.0000195860.94429.03     Document Type: Review

References (93)

1. Aaberg TM, Boldt HC, Murray TG. Uveal malignant melanoma. In: Parrish RK II, ed. The University of Miami Bascom Palmer Eye Institute Atlas of Ophthalmology. Boston: Butterworth-Heinemann, 2000:380-392.
2. Aaberg TM. Current clinical management options for uveal melanoma. Ophthalmol Clin North Am. 1999;12:177-181.
3. Hungerford JL. Current trends in the treatment of ocular melanoma by radiotherapy. Clin Experiment Ophthalmol. 2003;31:8-13.
4. Moore RF. Choroidal sarcoma treated by intraocular insertion of radon seeds. Br J Ophthalmol. 1930;14:145-152.
5. Stallard HB. A case of malignant melanoma of the choroid successfully treated by radon seeds. Trans Ophthalmol Soc U K. 1949;69:293-296.
6. Lommatzsch P. Treatment of choroidal melanoma with 106 Ru/106 Rh beta-ray applicators. Surv Ophthalmol. 1974;19:85-100.
7. Adams KS, Abramson DH, Ellsworth RM, et al. Cobalt plaque versus enucleation for uveal melanoma: comparison of survival rates. Br J Ophthalmol. 1988;72:494-497.
8. Cruess AF, Augsburger JJ, Shields JA, et al. Regression of posterior uveal melanomas following cobalt-60 plaque radiotherapy. Ophthalmology. 1984;91:1716-1719.
9. Finger PT, Buffa A, Mishra S, et al. Palladium 103 plaque radiation therapy for uveal melanoma. Clinical experience. Ophthalmology. 1994;101:256-263.
10. Gass JD. Comparison of prognosis after enucleation vs cobalt 60 irradiation of melanomas. Arch Ophthalmol. 1985;103:916-923.
11. Long RS, Galin MA, Rotman M. Conservative treatment of intraocular melanomas. Trans Am Acad Ophthalmol Otolaryngol. 1971;75:84-93.
12. MacFaul PA. Local radiotherapy in the treatment of malignant melanoma of the choroid. Trans Ophthalmol Soc U K. 1977;97:421-427.
13. Muller RP, Busse H, Potter R, et al. Results of high dose 106-ruthenium irradiation of choroidal melanomas. Int J Radiat Oncol Biol Phys. 1986;12:1749-1755.
14. Packer S. Iodine-125 radiation of posterior uveal melanoma. Ophthalmology. 1987;94:1621-1626.
15. Gass JD. Observation of suspected choroidal and ciliary body melanomas for evidence of growth prior to enucleation. Ophthalmology. 1980;87:523-528.
16. Robertson DM. Changing concepts in the management of choroidal melanoma. Am J Ophthalmol. 2003;136:161-170.
17. The Collaborative Ocular Melanoma Study Group. Mortality in patients with small choroidal melanoma. COMS report no. 4. Arch Ophthalmol. 1997;115:886-893.
18. Shields CL, Shields JA, Kiratli H, et al. Risk factors for growth and metastasis of small choroidal melanocytic lesions. Ophthalmology. 1995;102:1351-1361.
19. Stallard HB. Radiotherapy of malignant intraocular neoplasm. Br J Ophthalmol. 1948;32:618-639.
20. Augsburger JJ, Gamel JW, Lauritzen K, et al. Cobalt-60 plaque radiotherapy vs enucleation for posterior uveal melanoma. Am J Ophthalmol. 1990;109:585-592.
21. Augsburger JJ, Gamel JW, Shields JA. Cobalt plaque radiotherapy versus enucleation for posterior uveal melanoma: comparison of survival by prognostic index groups. Trans Am Ophthalmol Soc. 1989;87:348-359.
22. Karlsson UL, Augsburger JJ, Shields JA, et al. Recurrence of posterior uveal melanoma after 60Co episcleral plaque therapy. Ophthalmology. 1989;96:382-388.
23. Shields CL, Shields JA, Gündüz K, et al. Radiation therapy for uveal malignant melanoma. Ophthalmic Surg Lasers. 1998;29:397-409.
24. Finger PT, Lu DF, Buffa A, et al. Palladium-103 versus iodine-125 for ophthalmic plaque radiotherapy. Int J Radiat Oncol Biol Phys. 1993;27:849-854.
25. Kahn FM. Brachytherapy. In: Kahn FM, ed. Physics of Radiation Therapy. Baltimore, London: Williams & Wilkins; 1984:355.
26. Meli JA, Motakabbir KA. The effect of lead, gold and silver backings on dose near 125I seeds. Med Phys. 1993;20:1251-1256.
27. Packer S, Rotman M. Radiotherapy of choroidal melanoma with iodine-125. Ophthalmology. 1980;87:582-590.
28. Wu A, Krasin F. Film dosimetry analyses on the effect of gold shielding for iodine-125 eye plaque therapy for choroidal melanoma. Med Phys. 1990;17:843-846.
29. Earle J, Kline RW. Robertson. Selection of iodine-125 for the Collaborative Ocular Melanoma Study. Arch Ophthalmol. 1987;105:763-764.
30. Packer S, Rotman M, Salanitro P. Iodine-125 irradiation of choroidal melanoma. Clinical experience. Ophthalmology. 1984;91:1700-1708.
31. Packer S, Stoller S, Lesser ML, et al. Long-term results of iodine-125 irradiation of uveal melanoma. Ophthalmology. 1992;99:767-774.
32. Sealy R, le Roux PL, Rapley F, et al. The treatment of ophthalmic tumours with low-energy sources. Br J Radiol. 1976;49:551-554.
33. Finger PT. Radiation therapy for choroidal melanoma. Surv Ophthalmol. 1997;42:215-232.
34. Murray TG, Hayden BC, Boldt HC, et al. Clinical trials in uveal melanoma: patient characteristics and the treatment of intraocular tumors. In: Albert DM, Polans A, eds. Ocular Oncology. New York: Marcel Dekker, Inc; 2003:377-400.
35. Melia BM, Abramson DH, Albert DM, et al. Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years. COMS report no. 16. Ophthalmology. 2001;108:348-366.
36. Diener-West M, Earle JD, Fine SL, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS report no. 18. Arch Ophthalmol. 2001;119:969-982.
37. Diener-West M, Earle JD, Fine SL, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: II. Characteristics of patients enrolled and not enrolled. COMS report no. 17. Arch Ophthalmol. 2001;119:951-965.
38. Jampol LM, Moy CS, Murray TG, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19. Ophthalmology. 2002;109:2197-2206.
39. Char DH, Quivey JM, Castro JR, et al. Helium ions versus iodine 125 brachytherapy in the management of uveal melanoma. A prospective, randomized, dynamically balanced trial. Ophthalmology. 1993;100:1547-1554.
40. De Potter P, Shields CL, Shields JA, et al. Impact of enucleation versus plaque radiotherapy in the management of juxtapapillary choroidal melanoma on patient survival. Br J Ophthalmol. 1994;78:109-114.
41. Lommatzsch PK, Alberti W, Lommatzsch R, et al. Radiation effects on the optic nerve observed after brachytherapy of choroidal melanomas with 106Ru/106Rh plaques. Graefes Arch Clin Exp Ophthalmol. 1994;232:482-487.
42. De Potter P, Shields CL, Shields JA, et al. Plaque radiotherapy for juxtapapillary choroidal melanoma. Visual acuity and survival outcome. Arch Ophthalmol. 1996;114:1357-1365.
43. Lommatzsch PK, Lommatzsch R. Treatment of juxtapapillary melanomas. Br J Ophthalmol. 1991;75:715-717.
44. Yang CM, Olsen KR, Schwade JG, et al. Dose rate effect of 125I irradiation of normal rabbit eyes and experimental choroidal melanoma. Exp Eye Res. 1993;57:577-585.
45. Nag S, Quivey JM, Earle JD, et al. The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas. Int J Radiat Oncol Biol Phys. 2003;56:544-555.
46. Olsen KR, Murray TG, Johnson RN. Enucleation and plaque treatment. In: Albert DM, Jakobiec FA, eds. Principles and Practice of Ophthalmology, ed 2. Philadelphia: WB Saunders; 2000:5028-5126.
47. Robertson DM, Fuller DG, Anderson RE. A technique for accurate placement of episcleral iodine-125 plaques. Am J Ophthalmol. 1987;103:63-65.
48. Tabandeh H, Chaudhry NA, Murray TG, et al. Intraoperative echographic localization of iodine-125 episcleral plaque for brachytherapy of choroidal melanoma. Am J Ophthalmol. 2000;129:199-204.
49. Freire JE, De Potter P, Brady LW, et al. Brachytherapy in primary ocular tumors. Semin Surg Oncol. 1997;13:167-176.
50. Barash D, O'Brien JM. The role of ultrasound in the management of ocular tumors. Ophthalmol Clin North Am. 1999;12:205-211.
51. Harbour JW, Murray TG, Byrne SF, et al. Intraoperative echographic localization of iodine 125 episcleral radioactive plaques for posterior uveal melanoma. Retina. 1996;16:129-134.
52. Finger PT, Iezzi R, Esteveo M, et al. Diode-light transillumination for ophthalmic plaque localization around juxtapapillary choroidal melanomas. Int J Radiat Oncol Biol Phys. 1999;44:887-890.
53. Garretson BR, Robertson DM, Earle JD. Choroidal melanoma treatment with iodine 125 brachytherapy. Arch Ophthalmol. 1987;105:1394-1397.
54. Brovkina AF, Zarubei GD. Ciliochoroidal melanomas treated with a narrow medical proton beam. Arch Ophthalmol. 1986;104:402-404.
55. Fontanesi J, Meyer D, Xu S, et al. Treatment of choroidal melanoma with I-125 plaque. Int J Radiat Oncol Biol Phys. 1993;26:619-623.
56. Linstadt D, Castro J, Char D, et al. Long-term results of helium ion irradiation of uveal melanoma. Int J Radiat Oncol Biol Phys. 1990;19:613-618.
57. Lommatzsch PK, Kirsch IH. 106Ru/106Rh plaque radiotherapy for malignant melanomas of the choroid. With follow-up results more than 5 years. Doc Ophthalmol. 1988;68:225-238.
58. De Potter P, Shields CL, Shields JA. New treatment modalities for uveal melanoma. Curr Opin Ophthalmol. 1996;7:27-31.
59. Gragoudas ES, Seddon JM, Egan KM, et al. Metastasis from uveal melanoma after proton beam irradiation. Ophthalmology. 1988;95:992-999.
60. Lommatzsch PK, Dietrich B. The effect of orbital irradiation on the survival rate of patients with choroidal melanoma. Ophthalmologica. 1976;173:49-52.
61. Fontanesi J, Meyer D, Tai DL, et al. Effect of dose rate on local control and complications in ocular melanomas treated with high intensity 1251 plaques. Endocuriether/Hyperthermia Oncology. 1989;5:249.
62. Hall EJ. Time, dose, and fractionation in radiotherapy. In: Hall EJ, ed. Radiobiology for the Radiologist. Philadelphia: JB Lippincott Co; 1994:211-230.
63. Kindy-Degnan NA, Char DH, Castro JR, et al. Effect of various doses of radiation for uveal melanoma on regression, visual acuity, complications, and survival. Am J Ophthalmol 1989;107:114-120.
64. Trott KR. The optimal radiation dose per fraction for the treatment of malignant melanoma. Int J Radiat Oncol Biol Phys. 1992;20:905-907.
65. Yang CM, Olsen KR, Schwade JG, et al. Dose rate effect of 125I irradiation of normal rabbit eyes and experimental choroidal melanoma. Exp Eye Res. 1993;57:577-585.
66. Shields CL, Naseripour M, Cater J, et al. Plaque radiotherapy for large posterior uveal melanomas (> or = 8 mm thick) in 354 consecutive patients. Ophthalmology. 2002;109: 1838-1849.
67. Shields CL, Shields JA, De Potter P, et al. Treatment of non-resectable malignant iris tumors with custom designed plaque radiotherapy. Br J Ophthalmol. 1995;79:306-312.
68. Finger PT. Plaque radiation therapy for malignant melanoma of the iris and ciliary body. Am J Ophthalmol. 2001;132:328-335.
69. Gündüz K, Shields CL, Shields JA, et al. Radiation complications and tumor control after plaque radiotherapy of choroidal melanoma with macular involvement. Am J Ophthalmol. 1999;127:579-589.
70. Bosworth JL, Packer S, Rotman M, et al. Choroidal melanoma: I-125 plaque therapy. Radiology. 1988;169:249-251.
71. Busse H, Muller RP, Kroll P. Results of 106Ru/Rh-radiation of choroidal melanomas. Ann Ophthalmol. 1983;15:1146-1149.
72. Egan KE, Gragoudas ES, Seddon JM, et al. The risk of enucleation after proton beam irradiation of uveal melanoma. Ophthalmology. 1989;96:1377-1382.
73. Fries PD, Char DH, Crawford JB, et al. Sympathetic ophthalmia complicating helium ion irradiation of a choroidal melanoma. Arch Ophthalmol. 1987;105:1561-1564.
74. Gragoudas ES, Seddon JM, Egan KM, et al. Long-term results of proton beam irradiated uveal melanomas. Ophthalmology. 1987;94:349-353.
75. Munzenrider JE, Gragoudas ES, Seddon JM, et al. Conservative treatment of uveal melanoma: probability of eye retention after proton treatment. Int J Radiat Oncol Biol Phys. 1988;15:553-558.
76. Shields CL, Shields JA, Karlsson U, et al. Reasons for enucleation after plaque radiotherapy for posterior uveal melanoma. Clinical findings. Ophthalmology. 1989;96:919-923.
77. Diener-West M, Hawkins BS, Markowitz JA, et al. A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. Arch Ophthalmol. 1992;110:245-520.
78. Augsberger JJ, Gamel JW, Sardi VF, et al. Enucleation vs cobalt plaque radiotherapy for malignant melanomas of the choroid and ciliary body. Arch Ophthalmol. 1986;104:655-661.
79. Shields CL, Shields JA, Cater J, et al. Plaque radiotherapy for uveal melanoma: long-term visual outcome in 1106 consecutive patients. Arch Ophthalmol. 2000;118:1219-1228.
80. Gündüz K, Shields CL, Shields JA, et al. Radiation retinopathy following plaque radiotherapy for posterior uveal melanoma. Arch Ophthalmol. 1999;117:609-614.
81. Finger PT, Berson A, Szechter A. Palladium-103 plaque radiotherapy for choroidal melanoma: results of a 7-year study. Ophthalmology. 1999;106:606-613.
82. Summanen P, Immonen I, Heikkonen J, et al. Survival of patients and metastatic and local recurrent tumor growth in malignant melanoma of the uvea after ruthenium plaque radiotherapy. Ophthalmic Surg. 1993;24:82-90.
83. Rouberol F, Roy P, Kodjikian L, et al. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays). Am J Ophthalmol. 2004;137:893-900.
84. Lommatzsch PK, Werschnik C, Schuster E. Long-term follow-up of Ru-106/Rh-106 brachytherapy for posterior uveal melanoma. Graefes Arch Clin Exp Ophthalmol. 2000;238:129-137.
85. Gragoudas ES, Lane AM, Regan S, et al. An randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma. Arch Ophthalmol. 2000;118:773-778.
86. Brown GC, Shields JA, Sanborn G, et al. Radiation retinopathy. Ophthalmology. 1982;89:1494-1501.
87. Brown GC, Shields JA, Sanborn G, et al. Radiation optic neuropathy. Ophthalmology. 1982;89:1489-1493.
88. Davidorf FH, Pajka JT, Makley TA, et al. Radiotherapy of choroidal melanoma. An 18-year experience with radon. Arch Ophthalmol. 1987;105:352-355.
89. Hungerford JL. Current trends in the treatment of ocular melanoma by radiotherapy. Clin Experiment Ophthalmol. 2003;13:8-13.
90. Bill A. Ocular circulation. In: Moses RA, ed. Adler's Physiology of the Eye. St. Louis: Mosby; 1987:184-203.
91. Cantrill HL, Cameron JD, Ramsay RC, et al. Retinal vascular changes in malignant melanoma of the choroid. Am J Ophthalmol. 1984;97:411-418.
92. Reinhold HS, Endlich B. Tumour microcirculation as a target for hyperthermia. Int J Hyperthermia. 1986;2:111-137.
93. Char DH. Posterior uveal tumors. In: Char DH, ed. Clinical Ocular Oncology, ed 1. New York: Churchill Livingstone; 1989:91-149.